Although studies in mice or non-human primates are often used to make conclusions about human disease, these species do not always respond in the same way. In fact, recent studies show that acute responses to various types of inflammation are very similar between humans of different genetic backgrounds, but poorly correlate with supposedly equivalent mouse models. Thus, human studies that validate the conclusions made from studies in other species are not only important, but are necessary to understand mechanisms of human disease. Moreover, coordinated animal and human studies allow investigators to learn from each model, develop new hypotheses and design better experiments that in mice, will further dissect mechanisms of disease and |n humans, will validate the conclusions drawn from animal studies, since complex mechanistic studies cannot be ethically proposed in human subjects. Therefore, the goal of the human immunology core will be to enable the performance of human studies that will test key hypotheses of each project proposed in the Ul9 program. To achieve this goal. Core C will recruit human subjects and collect clinical samples and clinical information, validate the antigen-specific B cell tetramers in human clinical samples and provide the clinical infrastructure and research expertise for the analysis of virus-specific B and T cells from human samples. The clinical core will coordinate all aspects of the studies related to direct patient contact and specimen collection for the Projects of the U19

Public Health Relevance

Core C: Human Immunology, will provide the clinical infrastructure, knowledge and expertise to recruit human subjects, collect samples from human subjects and perform experiments using those clinical samples that will directly advance the goals of each of the projects in the U19. -

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-ZL-I (J1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Alabama Birmingham
United States
Zip Code
Tian, Yuan; Cox, Maureen A; Kahan, Shannon M et al. (2016) A Context-Dependent Role for IL-21 in Modulating the Differentiation, Distribution, and Abundance of Effector and Memory CD8 T Cell Subsets. J Immunol 196:2153-66
Tian, Yuan; Mollo, Sarah B; Harrington, Laurie E et al. (2016) IL-10 Regulates Memory T Cell Development and the Balance between Th1 and Follicular Th Cell Responses during an Acute Viral Infection. J Immunol 197:1308-21
Ballesteros-Tato, André; Randall, Troy D; Lund, Frances E et al. (2016) T Follicular Helper Cell Plasticity Shapes Pathogenic T Helper 2 Cell-Mediated Immunity to Inhaled House Dust Mite. Immunity 44:259-73
Baumgarth, Nicole (2016) B-1 Cell Heterogeneity and the Regulation of Natural and Antigen-Induced IgM Production. Front Immunol 7:324
Tian, Yuan; Zajac, Allan J (2016) IL-21 and T Cell Differentiation: Consider the Context. Trends Immunol 37:557-68
Xin, Gang; Schauder, David M; Lainez, Begoña et al. (2015) A Critical Role of IL-21-Induced BATF in Sustaining CD8-T-Cell-Mediated Chronic Viral Control. Cell Rep 13:1118-24
Waffarn, Elizabeth E; Hastey, Christine J; Dixit, Neha et al. (2015) Infection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulation. Nat Commun 6:8991
Baumgarth, Nicole; Waffarn, Elizabeth E; Nguyen, Trang T T (2015) Natural and induced B-1 cell immunity to infections raises questions of nature versus nurture. Ann N Y Acad Sci 1362:188-99
Kahan, Shannon M; Wherry, E John; Zajac, Allan J (2015) T cell exhaustion during persistent viral infections. Virology 479-480:180-93
Halliley, Jessica L; Tipton, Christopher M; Liesveld, Jane et al. (2015) Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow. Immunity 43:132-45

Showing the most recent 10 out of 14 publications